Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis.
Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders.
Is environmental radon gas associated with the incidence of neurodegenerative conditions? A retrospective study of multiple sclerosis in radon affected areas in England and Wales.
Reproducibility of T2 * mapping in the human cerebral cortex in vivo at 7 tesla MRI.
Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.
Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications.
Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions.
The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic.
Rational Design and Synthesis of Altered Peptide Ligands based on Human Myelin Oligodendrocyte Glycoprotein 35-55 Epitope: Inhibition of Chronic Experimental Autoimmune Encephalomyelitis in Mice.
The effects of a group-based cognitive behavioral therapy on people with multiple sclerosis: a randomized controlled trial.
Therapeutic plasma exchange in children with acute autoimmune central nervous system disorders.
Increased IL-17A but Decreased IL-27 Serum Levels in Patients with Multiple Sclerosis.
Retrograde degeneration of visual pathway: hemimacular thinning of retinal ganglion cell layer in progressive and active multiple sclerosis.
The Gender Gap in Multiple Sclerosis: Intersection of Science and Society.
Novel molecular insights into classical and alternative activation states of microglia as revealed by SILAC-based proteomics.
Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.
A single-group pilot feasibility study of cognitive behavioural therapy in people with multiple sclerosis with depressive symptoms.
The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases.
Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome?
Toxic hepatitis after concomitant interferon beta and aloe vera treatment in a patient with multiple sclerosis: A case report.
Political notebook.
The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis.
Costs of formal and informal home care and quality of life for patients with multiple sclerosis in sweden.
Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
Pages
« first
‹ previous
…
454
455
456
457
458
459
460
461
462
…
next ›
last »